Cargando…
The Role of Actin in Muscle Spasms in a Case Series of Patients with Advanced Basal Cell Carcinoma Treated with a Hedgehog Pathway Inhibitor
Basal cell carcinoma (BCC) is the most common cancer globally, with the incidence increasing worldwide by approximately 1% annually. While most cases of BCC can be treated surgically, advanced BCC often poses treatment challenges for patients unsuitable for, or refractory to, radiotherapy and surger...
Autores principales: | Teh, Natalie, Leow, Liang Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859007/ https://www.ncbi.nlm.nih.gov/pubmed/33200373 http://dx.doi.org/10.1007/s13555-020-00464-x |
Ejemplares similares
-
Clinical clearance of complex basal cell carcinoma in patients receiving sonidegib: A case series
por: Leow, Liang Joo, et al.
Publicado: (2021) -
Decreased coronary blood flow velocity in two patients with coronary microvascular spasm: case series(†)
por: Takahashi, Hiroshi, et al.
Publicado: (2018) -
Advanced basal cell carcinoma, the hedgehog pathway, and treatment options – role of smoothened inhibitors
por: Fecher, Leslie A, et al.
Publicado: (2015) -
Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma
por: Nix, Nancy M., et al.
Publicado: (2014) -
Effective treatment of locally advanced periocular basal cell carcinoma with oral hedgehog pathway inhibitor?
por: Hou, Xiaoyi, et al.
Publicado: (2020)